Deep Genomics Overview
Company Headquarters: Ontario, Canada
Founded: 2015
Workforce: ~200
Company Working: Deep Genomics is a biotechnology company that builds proprietary Artificial Intelligence (AI) and uses it to discover new ways to correct the effects of genetic mutations and develop personalized therapies for individuals with rare Mendelian and complex diseases. It offers cell and molecular biology, clinical development, molecular genetics, organic chemistry, preclinical development, and other solutions. The company's AI platform generates billions of data points using throughput assays and sophisticated robotics systems and creates dozens of engineered and validated machine learning systems to support drug development. This allows researchers to categorize, rank, interpret, and link genetic variants, whether they are therapeutic or natural. Furthermore, Deep Genomics serves customers in Canada.
Strategy
Deep Genomics aim is to build a new universe of genetic medicines using its machine learning-driven biomedical platform. It also plans for clinical innovation. Furthermore, it strives to invest in R&D to innovate and deliver better treatment options. Furthermore, it is also focusing on the expansion of the company in the new market such as genetic therapy.
